GRIFOLS | GRF - Cost Of Sales

Stock Price
10.87
Daily Change
0.03 0.28%
Monthly
-6.21%
Yearly
30.30%
Q1 Forecast
10.50

GRIFOLS reported EUR1.13B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alcon AG USD 1.16B 52M Sep/2025
Almirall EUR 193.79M 12.62M Jun/2025
Amadeus IT EUR 901.5M 358.4M Sep/2025
Amarin USD 16.89M 18.51M Mar/2025
argenx SE USD 109.43M 1.32M Sep/2025
AstraZeneca USD 2.8B 328M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Cie Automotive EUR 1.23B 135.91M Jun/2025
Demant DKK 2.89B 188M Dec/2025
Ence Energia y Celulosa EUR 131.3M 2.6M Sep/2025
Essilor EUR 5.31B 2.79B Jun/2025
Ferrovial EUR 747M 132M Jun/2025
Fresenius EUR 4.19B 62M Sep/2025
Fresenius Medical Care EUR 3.64B 65.63M Sep/2025
Galapagos EUR 84.73M 80.02M Sep/2025
Genmab DKK 57M 15M Jun/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.13B 15.63M Sep/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Inditex EUR 4.52B 658M Sep/2025
Merck EUR 2.1B 123M Sep/2025
Novartis USD 3.54B 217M Sep/2025
Philips EUR 2.39B 65M Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
UCB EUR 901M 50M Dec/2024
Viscofan EUR 204.26M 112.43M Sep/2025